… Data were independently extracted by two investigators (S. Mocellin and S. Pasquali) to
ensure homogeneity of data collection and to rule out any subjective influence in data gathering …

CONTEXT: Despite the large diffusion of robot-assisted radical prostatectomy (RARP),
literature and data on the oncologic outcome of RARP are limited. OBJECTIVE: Evaluate lymph …

Classification of cytokines as pro- versus anti-inflammatory might not apply to the pleiotropic
effects of interleukin-10 (IL-10). Several reports suggest that IL-10 enhances the function of …

Although interleukin-10 (IL-10) is commonly regarded as an anti-inflammatory, immunosuppressive
cytokine that favors tumor escape from immune surveillance, a wealth of evidence is …

… S- or N-nitrosylation, the reaction in which S-nitrosothiols (RSNO) and N-nitrosamines (RNNO)
are formed. Although classical chemical nomenclature defines ‘‘nitrosation’’ as addition …

… In the 1980s the NSABP C‐03 protocol compared MOF treatment with 6 months of 5‐FU
combined with the 5‐FU modulating agent Leucovorin in Dukes B and C colon cancers. A …

… Mouse undifferentiated hematopoietic cell lines (22) and acute monocytic leukemia of M5
type (S. Mandruzzato, unpublished data) express high levels of IL4Rα, therefore, another …

Tumor necrosis factor (TNF) is being utilized as an antineoplastic agent for the treatment of
patients with locally advanced solid tumors. However, its role in cancer therapy is debated. …

Purpose: To investigate whether the ratio between metastatic and examined lymph nodes (N
ratio) is a better prognostic factor as compared with traditional staging systems in patients …

… is S c (t), then the survival probability in the active group is [S c (t)] h , where h is the meta‐analysis
HR comparing the treatment groups: mortality rates are then simply calculated as 1‐S. …